Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ontak with aggressive chemotherapy and ASCT in peripheral T-cell lymphoma
NCT00632827Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Jul 2008
- Primary completion
- Jun 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in peripheral T-cell lymphoma (PTCL), sponsored by University of California, San Francisco. Started Jul 2008; status: terminated.
02
Drugs
denileukin diftitox
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00632827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632827.